Literature DB >> 35246800

MYOCD is Required for Cardiomyocyte-like Cells Induction from Human Urine Cells and Fibroblasts Through Remodeling Chromatin.

Xiangyu Zhang1, Lijun Chen2,3,4, Xingnan Huang5, Huan Chen6, Baomei Cai6, Yue Qin3,4,7, Yating Chen2,3,4, Sihua Ou2,3,4, Xiaoxi Li3,4, Zichao Wu2,3,4, Ziyu Feng6, Mengying Zeng6, Wenjing Guo3,4, Heying Li3,4, Chunhua Zhou3,4, Shengyong Yu3,4, Mengjie Pan2,6,7, Jing Liu3,4,6, Kai Kang8, Shangtao Cao9, Duanqing Pei10.   

Abstract

Despite direct reprogramming of human cardiac fibroblasts into induced cardiomyocytes (iCM) holds great potential for heart regeneration, the mechanisms are poorly understood. Whether other human somatic cells could be reprogrammed into cardiomyocytes is also unknown. Here, we report human urine cells (hUCs) could be converted into CM-like cells from different donors and the related chromatin accessibility dynamics (CAD) by assay for transposase accessible chromatin(ATAC)-seq. hUCs transduced by MEF2C, TBX5, MESP1 and MYOCD but without GATA4 expressed multiple cardiac specific genes, exhibited Ca2+ oscillation potential and sarcomeric structures, and contracted synchronously in coculture with mouse CM. Additionally, we found that MYOCD is required for both closing and opening critical loci, mainly by hindering the opening of loci enriched with motifs for the TEAD and AP1 family and promoting the closing of loci enriched with ETS motifs. These changes differ partially from CAD observed during iCM induction from human fibroblasts. Collectively, our study offers one practical platform for iCM generation and insights into mechanisms for iCM fate determination.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ATAC-seq; Cardiac reprogramming; Chromatin accessibility dynamics; Human urine cells; MYOCD

Mesh:

Substances:

Year:  2022        PMID: 35246800     DOI: 10.1007/s12015-022-10339-7

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   6.692


  40 in total

1.  Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.

Authors:  Nan Cao; Zumei Liu; Zhongyan Chen; Jia Wang; Taotao Chen; Xiaoyang Zhao; Yu Ma; Lianju Qin; Jiuhong Kang; Bin Wei; Liu Wang; Ying Jin; Huang-Tian Yang
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

Review 2.  Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.

Authors:  Taketaro Sadahiro; Shinya Yamanaka; Masaki Ieda
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 3.  Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2020-10-01       Impact factor: 24.633

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

Authors:  Masaki Ieda; Ji-Dong Fu; Paul Delgado-Olguin; Vasanth Vedantham; Yohei Hayashi; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

8.  Heart repair by reprogramming non-myocytes with cardiac transcription factors.

Authors:  Kunhua Song; Young-Jae Nam; Xiang Luo; Xiaoxia Qi; Wei Tan; Guo N Huang; Asha Acharya; Christopher L Smith; Michelle D Tallquist; Eric G Neilson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  Nature       Date:  2012-05-13       Impact factor: 49.962

9.  Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts.

Authors:  Yuji Shiba; Sarah Fernandes; Wei-Zhong Zhu; Dominic Filice; Veronica Muskheli; Jonathan Kim; Nathan J Palpant; Jay Gantz; Kara White Moyes; Hans Reinecke; Benjamin Van Biber; Todd Dardas; John L Mignone; Atsushi Izawa; Ramy Hanna; Mohan Viswanathan; Joseph D Gold; Michael I Kotlikoff; Narine Sarvazyan; Matthew W Kay; Charles E Murry; Michael A Laflamme
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

10.  Chemically defined generation of human cardiomyocytes.

Authors:  Paul W Burridge; Elena Matsa; Praveen Shukla; Ziliang C Lin; Jared M Churko; Antje D Ebert; Feng Lan; Sebastian Diecke; Bruno Huber; Nicholas M Mordwinkin; Jordan R Plews; Oscar J Abilez; Bianxiao Cui; Joseph D Gold; Joseph C Wu
Journal:  Nat Methods       Date:  2014-06-15       Impact factor: 28.547

View more
  1 in total

1.  Generation of mitochondria-rich kidney organoids from expandable intermediate mesoderm progenitors reprogrammed from human urine cells under defined medium.

Authors:  Yapei Yuan; Huan Chen; Sihua Ou; Baomei Cai; Ruifang Zhang; Yue Qin; Mengjie Pan; Shangtao Cao; Duanqing Pei; Fan Fan Hou
Journal:  Cell Biosci       Date:  2022-10-15       Impact factor: 9.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.